Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q3 2024 Earnings Conference Call November 5, 2024 4:30 PM ET Company Participants Sharon Klahre – Head, Investor RelationsMichael Metzger – Chief Executive OfficerNeil Gallagher – President & Head, R&DSteve Closter – Chief Commercial OfficerKeith Goldan – Chief Financial OfficerAnjali Ganguli…
Money & Finance
There are significant tax-reduction opportunities available when employer stock is held in a 401(k) plan. The opportunities are more significant now, as are the…
Most people at or near retirement age will say they want to…
Subsidizing home care for aging adults has been discussed in decades past.…
A new push to move credit card users to a digital statement…
Investing
Losses from Hurricane Milton could reach as high as $34 billion, according to an early estimate of both flood and…
Tech & Innovation
IBM aims to be “client zero” of the AI products it sells to clients, marketing chief Jonathan Adashek said.He said AI has augmented the work IBM…
